{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:21:06Z","timestamp":1791386466513,"version":"4.3.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the value of dual-phase parenchymal blood volume (PBV) C-arm mounted cone-beam-CT (CBCT) to enable assessment of radiopaque, doxorubicin-loaded drug-eluting embolics (rDEE) based on the visual degree of embolization, embolic density and residual tumor perfusion as early predictors for tumor recurrence after transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and Methods<\/jats:title>\n                <jats:p>Thirty patients (50 HCCs) were prospectively enrolled, underwent cross-sectional imaging before and after TACE using 100\u2013300\u00a0\u00b5m rDEE and had regular follow-up examinations. Directly before and after the TACE procedure, PBV-CBCT was acquired. The response was evaluated and compared to visual degree of embolization (DE) and embolic density (ED) of rDEE deposits, as well as the presence of residual tumor perfusion (RTP) derived from PBV-CBCT. Outcome was assessed by mid-term tumor response applying mRECIST and patient survival after 12\u00a0months.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>RTP was detected in 16 HCCs and correlated negatively with DE (<jats:italic>p<\/jats:italic>\u2009=\u2009.03*) and ED (<jats:italic>p<\/jats:italic>\u2009=\u2009.0009*). The absence of RTP significantly improved lesion-based mid-term response rates regarding complete response (CR, 30\/34 (88%) vs 2\/16 (12.5%), <jats:italic>p<\/jats:italic>\u2009=\u2009.0002*), lesion-based complete response rate was 75% (21\/28) for DE\u2009\u2265\u200950% vs. 50% (11\/22) for DE\u2009&lt;\u200950% (<jats:italic>p<\/jats:italic>\u2009=\u2009\u2009.08) and 82% (27\/33) for ED\u2009\u2265\u20092 vs. 29% for ED\u2009&lt;\u20092 (5\/17), <jats:italic>p<\/jats:italic>\u2009=\u2009\u2009.005*). Thirteen patients were treated with re-TACE within 12\u00a0months, 11 of which had shown RTP. 12-month survival rate was 93%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Residual tumor perfusions as assessed by PBV-CBCT during rDEE-TACE proved to be the best parameter to predict mid-term response.<\/jats:p>\n                <jats:p>\u201cLevel of Evidence: Level 3\u201d<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00270-021-02858-6","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T17:02:40Z","timestamp":1621616560000},"page":"1403-1413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: Impact of Embolic Density and Residual Tumor Perfusion on Tumor Recurrence and Survival"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9193-6116","authenticated-orcid":false,"given":"Christer","family":"Ruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Artzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Syha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Partovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Horger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Gr\u00f6zinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"1","key":"2858_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0033-1333648","volume":"30","author":"R Lencioni","year":"2013","unstructured":"Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol. 2013;30(1):3\u201311.","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"2858_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jvir.2011.10.019","volume":"23","author":"MR Dreher","year":"2012","unstructured":"Dreher MR, Sharma KV, Woods DL, Reddy G, Tang Y, Pritchard WF, et al. Radiopaque drug-eluting beads for transcatheter embolotherapy experimental study of drug penetration and coverage in swine. Journal of vascular and interventional radiology JVIR. 2012;23(2):257-64 e4.","journal-title":"Journal of vascular and interventional radiology JVIR"},{"issue":"2","key":"2858_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/RLI.0000000000000215","volume":"51","author":"R Syha","year":"2016","unstructured":"Syha R, Grozinger G, Grosse U, Maurer M, Zender L, Horger M, et al. Parenchymal blood volume assessed by c-arm-based computed tomography in immediate posttreatment evaluation of drug-eluting bead transarterial chemoembolization in hepatocellular carcinoma. Invest Radiol. 2016;51(2):121\u20136.","journal-title":"Invest Radiol"},{"issue":"6","key":"2858_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jvir.2008.02.002","volume":"19","author":"RC Orth","year":"2008","unstructured":"Orth RC, Wallace MJ, Kuo MD. Technology Assessment Committee of the Society of Interventional R. C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology. Journal of vascular and interventional radiology: JVIR. 2008;19(6):814\u201320.","journal-title":"Journal of vascular and interventional radiology: JVIR"},{"issue":"1","key":"2858_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40644-019-0260-2","volume":"19","author":"M Dioguardi Burgio","year":"2019","unstructured":"Dioguardi Burgio M, Sartoris R, Libotean C, Zappa M, Sibert A, Vilgrain V, et al. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response. Cancer Imaging. 2019;19(1):75.","journal-title":"Cancer Imaging"},{"issue":"3","key":"2858_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jvir.2018.09.001","volume":"30","author":"C Ruff","year":"2019","unstructured":"Ruff C, Grozinger G, Syha R, Elser S, Partovi S, Bitzer M, et al. Transarterial chemoembolization of hepatocellular carcinoma using radiopaque drug-eluting embolics: how to pursue periprocedural cross-sectional imaging? Journal of vascular and interventional radiology: JVIR. 2019;30(3):380-9 e4.","journal-title":"Journal of vascular and interventional radiology: JVIR"},{"issue":"4","key":"2858_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00270-012-0423-z","volume":"35","author":"A Basile","year":"2012","unstructured":"Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol. 2012;35(4):765\u201374.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"2858_CR8","first-page":"1325","volume":"24","author":"R Syha","year":"2012","unstructured":"Syha R, Ketelsen D, Heller S, Schmehl J, Mangold S, Heuschmid M, et al. Hepatocellular carcinoma: initial tumour response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST. Eur J Gastroenterol Hepatol. 2012;24(11):1325\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"2858_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40644-018-0151-y","volume":"18","author":"T Zitzelsberger","year":"2018","unstructured":"Zitzelsberger T, Syha R, Grozinger G, Partovi S, Nikolaou K, Grosse U. Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization. Cancer Imaging. 2018;18(1):16.","journal-title":"Cancer Imaging"},{"key":"2858_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jconrel.2017.02.001","volume":"250","author":"K Ashrafi","year":"2017","unstructured":"Ashrafi K, Tang Y, Britton H, Domenge O, Blino D, Bushby AJ, et al. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI. J Control Release. 2017;250:36\u201347.","journal-title":"J Control Release"},{"issue":"37","key":"2858_CR11","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.3748\/wjg.14.5738","volume":"14","author":"G Chen","year":"2008","unstructured":"Chen G, Ma DQ, He W, Zhang BF, Zhao LQ. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2008;14(37):5738\u201343.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2858_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/RLI.0b013e3181e07516","volume":"45","author":"SH Choi","year":"2010","unstructured":"Choi SH, Chung JW, Kim HC, Baek JH, Park CM, Jun S, et al. The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model. Invest Radiol. 2010;45(7):427\u201336.","journal-title":"Invest Radiol"},{"issue":"47","key":"2858_CR13","first-page":"5993","volume":"16","author":"D Ippolito","year":"2010","unstructured":"Ippolito D, Bonaffini PA, Ratti L, Antolini L, Corso R, Fazio F, et al. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol. 2010;16(47):5993\u20136000.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2858_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/RLI.0b013e3182199bb5","volume":"47","author":"T Jiang","year":"2012","unstructured":"Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol. 2012;47(1):11\u20137.","journal-title":"Invest Radiol"},{"issue":"1","key":"2858_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/0284185114566442","volume":"57","author":"S Kaufmann","year":"2016","unstructured":"Kaufmann S, Schulze M, Spira D, Horger M. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report. Acta Radiol. 2016;57(1):8\u201312.","journal-title":"Acta Radiol"},{"issue":"2","key":"2858_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/RLI.0000000000000105","volume":"50","author":"H Chandarana","year":"2015","unstructured":"Chandarana H, Block TK, Ream J, Mikheev A, Sigal SH, Otazo R, et al. Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction. Invest Radiol. 2015;50(2):88\u201394.","journal-title":"Invest Radiol"},{"issue":"12","key":"2858_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/RLI.0000000000000586","volume":"54","author":"J Weiss","year":"2019","unstructured":"Weiss J, Ruff C, Grosse U, Grozinger G, Horger M, Nikolaou K, et al. Assessment of hepatic perfusion using GRASP MRI: bringing liver MRI on a new level. Invest Radiol. 2019;54(12):737\u201343.","journal-title":"Invest Radiol"},{"issue":"9","key":"2858_CR18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ejrad.2014.05.040","volume":"83","author":"D Ippolito","year":"2014","unstructured":"Ippolito D, Fior D, Bonaffini PA, Capraro C, Leni D, Corso R, et al. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients. Eur J Radiol. 2014;83(9):1665\u201371.","journal-title":"Eur J Radiol"},{"issue":"6","key":"2858_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jvir.2010.02.031","volume":"21","author":"KV Sharma","year":"2010","unstructured":"Sharma KV, Dreher MR, Tang Y, Pritchard W, Chiesa OA, Karanian J, et al. Development of \u201cimageable\u201d beads for transcatheter embolotherapy. J Vasc Interv Radiol. 2010;21(6):865\u201376.","journal-title":"J Vasc Interv Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-021-02858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-021-02858-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-021-02858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T15:11:23Z","timestamp":1629731483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-021-02858-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2858"],"URL":"https:\/\/doi.org\/10.1007\/s00270-021-02858-6","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.<b>:<\/b>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and \/ or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}